Trials / Completed
CompletedNCT01254825
The Efficacy of Adductor-Canal-Block (ACB) in Patients After Knee Arthroscopy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Glostrup University Hospital, Copenhagen · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The Purpose of this study is to determine whether Adductor-Canal-Block (ACB) is superior to placebo when it comes to analgetic efficacy after Knee-Arthroscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Adductor-Canal-Block, Ropivacain | Ultrasound-guided ACB; 30 mL Ropivacain 7,5 mg/mL. Single dose. |
| PROCEDURE | Adductor Canal Block, Placebo (saline) | Ultrasound-guided Adductor Canal Block; 30 mL Saline. Single dose. |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2010-12-07
- Last updated
- 2012-09-11
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01254825. Inclusion in this directory is not an endorsement.